Khosla Ventures helps seed a next-gen regenerative medicines startup boasting AI-based stem cell culturing technology

(From left to right) Cellino co-founders Marinna Madrid, Nabiha Saklayen, and Matthias Wagner https://endpts.com/khosla-ventures-helps-seed-a-next-gen-regenerative-medicines-startup-boasting-ai-based-stem-cell-culturing-technology/

Rate this:

Read Article →

Army Prepared to Sacrifice Unit Readiness to Defeat COVID-19, McConville Says

U.S. Army Soldiers and a FEMA employee work together at a mass vaccination site at California State University, Los Angeles, Feb. 15, 2021. (U.S. Army National Guard/Spc. Simone Lara) https://www.military.com/daily-news/2021/02/17/army-prepared-sacrifice-unit-readiness-defeat-covid-19-mcconville-says.html?ESRC=eb_210218.nl

Rate this:

Read Article →

Dr Kiara Bruggeman is engineering groundbreaking stroke treatments

Dr Kiara Bruggeman works with nanotechnology to create an environment where stem cells can be encouraged to replace damaged cells after a stroke. Picture: Sitthixay Ditthavong https://www.canberratimes.com.au/story/7061984/science-is-magic-dr-kiara-bruggeman-is-engineering-groundbreaking-stroke-treatments/

Rate this:

Read Article →

A Scalable Suspension Platform for Generating High-Density Cultures of Universal Red Blood Cells from Human Induced Pluripotent Stem Cells

https://www.cell.com/stem-cell-reports/fulltext/S2213-6711(20)30456-2?elqTrackId=12015f500d2e45ab89da9f5b9100a34d&elq=8805066ccff94f50b830b66176b9a0d3&elqaid=30273&elqat=1&elqCampaignId=10609&goal=0_b5222628eb-231646ac23-420332391&mc_cid=231646ac23&mc_eid=813bc0123d

Rate this:

Read Article →

Impact of the COVID-19 pandemic on persons with multiple sclerosis: Early findings from a survey on disruptions in care and self-reported outcomes

https://www.docwirenews.com/condition-center/multiple-sclerosis-knowledge-hub/impact-of-the-covid-19-pandemic-on-persons-with-multiple-sclerosis-early-findings-from-a-survey-on-disruptions-in-care-and-self-reported-outcomes/

Rate this:

Read Article →

Mesoblast shares savaged on poor trial results for COVID treatment

Mesoblast chief executive Silviu Itescu. The company was hoping to show its flagship product, remestemcel-L, would help patients with moderate to severe respiratory distress because of coronavirus.CREDIT:CREDIT: ARSINEH HOUSPIAN https://www.smh.com.au/business/companies/mesoblast-shares-savaged-on-poor-covid-trial-results-20201218-p56onp.html

Rate this:

Read Article →

In a stem cell experiment that seemingly failed, scientists see a possible way to prevent a devastating disease

In the new study, fertilized mouse eggs, made from stem cells, divided into two, four, and eight cells, but no further. COURTESY KATSUHIKO HAYASHI https://www.statnews.com/2020/12/16/stem-cell-experiment-scientists-see-possible-way-to-prevent-devastating-inherited-disease/

Rate this:

Read Article →